database > company
Eleme Medical
HCID Member | Medical Devices & Tech
Heron Cove Office Park, 10 Al Paul Lane, Suite 102
Merrimack, NH 03054 USA
phone:603-816-1920
fax:603-882-4762
Symbol Private
Founded 0
Employees 50
     www.elememedical.com
Research Sector Medical Devices & Tech
Summary Description
Elem Medical, an emerging venture backed aesthetics company, is dedicated to providing market-leading technology in all areas of body shaping. SmoothShapes system with Photomology technology is the company's preeminent product.
Management
Nancy M. Briefs, President,Chief Executive Officer; Christopher Joyce, Vice President and Chief Financial Officer; William McGrail, Vice President, Research and Development; Michail Pankratov, MD, PhD, Vice President, Regulatory & Clinical Affairs; Marcel Besse, Vice President, Sales
Keywords
causes of cellulite, smoothshapes system, Aesthetics, cellulite, body shaping, photomology, fat, adipose, laser, device, Eleme, Elemé

Comment | Printable Version | Modify profile Oct. 14, 2009

Description
Cellulite can't be controlled or improved by diet or exercise.
More than 85% of women will develop it at some point in their life; even athletes and supermodels. Dimpled, orange-peel-like skin that is bumpy and lax is actually the outward symptom of cellulite. Cellulite is a skin condition that results from enlarged fat cells trapped in an inflexible network of collagen located in the hypodermis. Women's skin visibly displays cellulite because their subcutaneous fat layer is separated by thin vertical columns in contrast to a crisscross network in men. Several factors contribute to the underlying causes of cellulite. These include: genetics, hormones, vascular changes and inflammation.
Products / Services
The SmoothShapes system with Photomology technology, addresses both the physical manifestations of cellulite and its underlying causes.
The SmoothShapes system is based on the company's proprietary Photomology platform, a process that treats cellulite and subcutaneous fat by combining dynamic light and laser energy along with vacuum and massage to stimulate the restoration of healthy cell activity. The system addresses both the physical manifestations of cellulite and its underlying causes providing longer lasting results that patients can see and feel. SmoothShapes treatments feel like a deep tissue massage; patients find it relaxing. There is no pain medication required when receiving treatment and there is no downtime. A typical treatment protocol is eight treatments, twice a week for four weeks. Treatment time is 20 minutes for a set of body parts (for example back of legs or buttocks). SmoothShapes helps women achieve SmoothThighs, SmoothButtocks, SmoothArms, SmoothKnees, SmoothHips, SmoothAbdomen, SmoothWaist and SmoothBack.
Technology / Differentiation
The device's vacuum component positions the skin for optimal laser and light penetration. SmoothShapes' 915nm laser penetrates into tissue and is preferentially absorbed by lipids causing fat liquefaction; 650nm light energy makes the cell membrane permeable, allowing liquefied fat to move into the interstitial space where the contoured rollers of the SmoothShapes' device assist in evacuating the liquefied fat into the lymphatic system. The 650 also improves the cells' metabolism and stimulates new collagen production. Results for patients are improved appearance of cellulite with tighter, smoother skin. In a 74 patient, multicenter, prospective, randomized and controlled clinical study of the SmoothShapes system ("Physiological effects of transcutaneous multiwavelength laser light administration"), 81 percent of treated patients showed a "significant volumetric reduction in subcutaneous fat" in treated vs. untreated leg, (Abt Associates Clinical Study Report). Although not part of the protocol, five patients from the study had elective MRIs 13 months post treatment and 4 of the 5, or 80%, had maintained their result.
Market / Customers
In 2006, the body shaping market generated $4.5 billion in device sales, procedures and fees. By 2011, the market could grow to $8.1 billion, says Michael Moretti, in his Global Body Shaping Market Analysis, published in 2006. Expansion will be "driven both by rising demand from consumers and expanding supply from practitioners", says Moretti. Targeted markets include plastic surgeons, dermatologists, OB/ GYN and primary care specialists, medical spas, aesthetic clinics and executive health facilities.
Status
In July 2008, Eleme Medical raised $18 million in a "Series C" financing led by L Capital Partners. The round also included Hambrecht & Quist. The funds will be used to commercialize the SmoothShapes System and to further the company's pipeline of body shaping technologies.


2009-11-22-2961